- Home
- PCRX vs AMN Comparison
PCRX vs AMN Comparison
Compare PCRX & AMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- AMN
- Stock Information
- Founded
- PCRX 2006
- AMN 1985
- Country
- PCRX United States
- AMN United States
- Employees
- PCRX N/A
- AMN N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- AMN Assisted Living Services
- Sector
- PCRX Health Care
- AMN Health Care
- Exchange
- PCRX Nasdaq
- AMN Nasdaq
- Market Cap
- PCRX 1.1B
- AMN 1.0B
- IPO Year
- PCRX 2011
- AMN 2001
- Fundamental
- Price
- PCRX $24.65
- AMN $18.49
- Analyst Decision
- PCRX Buy
- AMN Hold
- Analyst Count
- PCRX 9
- AMN 8
- Target Price
- PCRX $30.11
- AMN $38.50
- AVG Volume (30 Days)
- PCRX 1.2M
- AMN 871.6K
- Earning Date
- PCRX 05-06-2025
- AMN 05-08-2025
- Dividend Yield
- PCRX N/A
- AMN N/A
- EPS Growth
- PCRX N/A
- AMN N/A
- EPS
- PCRX N/A
- AMN N/A
- Revenue
- PCRX $700,966,000.00
- AMN $2,983,781,000.00
- Revenue This Year
- PCRX $9.48
- AMN N/A
- Revenue Next Year
- PCRX $11.31
- AMN $3.63
- P/E Ratio
- PCRX N/A
- AMN N/A
- Revenue Growth
- PCRX 3.85
- AMN N/A
- 52 Week Low
- PCRX $11.16
- AMN $18.15
- 52 Week High
- PCRX $31.67
- AMN $70.07
- Technical
- Relative Strength Index (RSI)
- PCRX 51.22
- AMN 31.81
- Support Level
- PCRX $24.10
- AMN $18.15
- Resistance Level
- PCRX $25.35
- AMN $19.97
- Average True Range (ATR)
- PCRX 1.49
- AMN 1.26
- MACD
- PCRX 0.01
- AMN -0.26
- Stochastic Oscillator
- PCRX 48.89
- AMN 8.92
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About AMN AMN Healthcare Services Inc
AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are; nurse and allied solutions, physician and leadership solutions, and technology and workforce solutions. A majority of its revenue is generated from the nurse and allied solutions segment which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.